Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Treasury Shares (2016 - 2025)

Lipocine's Treasury Shares history spans 11 years, with the latest figure at $40712.0 for Q3 2025.

  • For Q3 2025, Treasury Shares changed 0.0% year-over-year to $40712.0; the TTM value through Sep 2025 reached $40712.0, changed 0.0%, while the annual FY2024 figure was $40712.0, 0.0% changed from the prior year.
  • Treasury Shares reached $336.0 in Q3 2025 per LPCN's latest filing, roughly flat from $336.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $840336.0 in Q1 2022 to a low of $336.0 in Q4 2022.
  • Average Treasury Shares over 5 years is $54799.2, with a median of $336.0 recorded in 2022.
  • The largest YoY upside for Treasury Shares was 0.0% in 2021 against a maximum downside of 0.0% in 2021.
  • A 5-year view of Treasury Shares shows it stood at $40712.0 in 2021, then changed by 0.0% to $40712.0 in 2022, then changed by 0.0% to $40712.0 in 2023, then changed by 0.0% to $40712.0 in 2024, then changed by 0.0% to $40712.0 in 2025.
  • Per Business Quant, the three most recent readings for LPCN's Treasury Shares are $40712.0 (Q3 2025), $40712.0 (Q2 2025), and $40712.0 (Q1 2025).